# Typhoid Fever: Combined vs. Single Antibiotic Therapy

> **NCT02224040** · PHASE4 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Typhoid Fever

## Interventions

- **DRUG:** ceftriaxone
- **DRUG:** ceftriaxone and azithromycin
- **DRUG:** azithromycin
- **DRUG:** azithromycin and cefixime

## Key facts

- **NCT ID:** NCT02224040
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224040, "Typhoid Fever: Combined vs. Single Antibiotic Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02224040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*